Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Beijing announced a 10 billion RMB ($1.5 billion) fund to...
In a surprising move, Eli Lilly said it will close its...
Eli Lilly will build a bricks and mortar center dedicated...
For the first time in 29 years, the industry's most...
It's earnings season, and almost every day for the past...
Pharmaron, China’s third-largest CRO, announced a...
Simcere Pharma, like many US-listed China biopharmas, has...
Dr. Arthur Taveras, President and CSO of ChemPartner,...
Shanghai ChemPartner, a CRO/CMO, has closed its reverse...
The Keynote Panel from the recently...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China